VulCur Medtech


Advanced care for chronic wounds

Read more

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 868406

eurostars Headstart

WHAT WE DO

We are developing a medical grade laser device for killing biofilm-producing bacteria in chronic wounds, thereby preventing amputations and unnecessary use of antibiotics.

KILLS BACTERIA

Our technology is capable of killing bacteria in a three-dimensional grid in the wound site without the need of antibiotics.

LASER PRECISION

Using high precision lasers and controlled energy bursts, we leave healthy human cells unharmed while denaturing the biofilm-producing bacteria.

COMPACT

The device is mobile and can be operated by a single healthcare professional.

Partners

Icons made by Freepik from www.flaticon.com
Icons made by Good Ware from www.flaticon.com